Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection

被引：0
|
作者：
Majdi N. Al-Hasan
Avery N. Nelson
Julie Ann Justo
Helmut Albrecht
Joseph Kohn
P. Brandon Bookstaver
机构：
[1] University of South Carolina School of Medicine,Department of Medicine
[2] Palmetto Health USC Medical Group,Department of Clinical Pharmacy and Outcomes Sciences
[3] University of South Carolina College of Pharmacy,Department of Pharmacy
[4] Palmetto Health Richland,undefined
来源：
Infection | 2018年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 284
页数：1
相关论文
共 50 条
  • [21] Effects of antimicrobial therapy duration and class on risk of antimicrobial-resistant Gram-negative bacillus bloodstream infection in patients with AML
    Huggins, Jonathan
    Barnett, Ian
    David, Michael Z.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [22] TREATMENT OF GRAM-NEGATIVE BACTEREMIA IN PATIENTS WITH CANCER AND GRANULOCYTOPENIA - REPLY
    CALANDRA, T
    GLAUSER, MP
    KLASTERSKY, J
    GAYA, H
    ZINNER, SH
    MEUNIER, F
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25): : 1696 - 1696
  • [23] Shorter Versus Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia: Time for a Tailored Duration?
    Dudoignon, Emmanuel
    Camelena, Francois
    de Tymowski, Christian
    Lafaurie, Matthieu
    Depret, Francois
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (02) : 577 - 579
  • [24] EFFICACY OF SHORT DURATION THERAPY FOR GRAM-NEGATIVE BACTEREMIA IN CRITICALLY ILL TRAUMA PATIENTS.
    Hill, David
    Wood, G.
    Magnotti, Louis
    Swanson, Joseph
    Boucher, Bradley
    Schroeppel, Thomas
    Croce, Martin
    Fabian, Timothy
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U100 - U101
  • [25] Endoscopic Source Control of Gram-Negative Bacteremia Secondary to Foreign Body Ingestion - A Rare Case
    Al-Zakwani, Mohammed
    Shah, Pir Ahmad
    El Kurdi, Bara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1662 - S1662
  • [26] Is bacteremia the decisive factor for the duration of antimicrobial therapy in bacteremic urinary tract infections? Reply
    Naess, Are
    Eide, Geir Egil
    Sjursen, Haakon
    INFECTION, 2018, 46 (02) : 279 - 280
  • [27] Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
    Al-Hasan, Majdi N.
    ANTIBIOTICS-BASEL, 2020, 9 (12):
  • [28] Predictive model of antimicrobial-resistant Gram-negative bacteremia at the ED
    Chiang, Wen-Chu
    Chen, Shey-Ying
    Chien, Kuo-Liong
    Wu, Grace Hui-Min
    Yen, Amy Ming-Fang
    Su, Chan-Ping
    Lee, Chien-Chang
    Chen, Yee-Chun
    Chang, Shan-Chwen
    Chen, Shyr-Chyr
    Chen, Wen-Jone
    Chen, Tony Hsiu-Hsi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2007, 25 (06): : 597 - 607
  • [29] Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia - Reply
    Leibovici, L
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2593 - 2594
  • [30] Monotherapy vs. combination therapy for gram-negative bacteremia
    Barza, M
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1997, 6 (07) : 417 - 418
12345